How Financial Sales Pitches Hide the Real Cost of Investing: A Red-Flag Guide

The financial products advertised most aggressively tend to be the most profitable for the firm selling them, which often makes them the least profitable for the person buying them. The marketing budget is not free; it is recovered from investors through fees, spreads, and the price of the product. A heavily promoted fund has to pay for the promotion, and that cost lands on the buyer.

This is a guide to the sales pitch itself: the specific tactics that make a product feel attractive while the real costs, risks, and incentives stay out of view. The goal is not to argue that complexity is a scam. Some complex products solve real problems for the right investor. The goal is a working rule: a marketed product carries the burden of proof, and the more a pitch leans on a feature you can feel, the harder you should look for the tradeoff you will live with.

The framework here, especially the five marketing tactics and the loss-leader idea below, is inspired by Ben Felix of PWL Capital and his video “The Biggest Problem in Investing Right Now.” The factual claims are sourced to the primary research cited at the end.¹

Incentives, not villainy

You do not need to believe the industry is malicious. You only need to understand incentives. Economists George-Marios Gabaix and David Laibson showed how firms can profit by advertising an attractive headline price while shrouding less-visible add-on costs, and how competition does not always compete those shrouded costs away.² Disclosure helps, but it is an incomplete fix. People routinely fail to act on disclosed conflicts, and the SEC has emphasized that disclosing a conflict does not by itself satisfy a best-interest obligation when the conflict remains material.³

So the heuristic is simple. When a product is marketed hard, ask who pays for the marketing and who collects the economics. The answer raises the bar the product has to clear before it belongs in your portfolio.

Five tactics that sell the feeling and hide the cost

Most persuasive financial pitches run on a small set of techniques, a grouping drawn from Ben Felix’s video.¹ Once you can name them, they lose much of their power.

• Transference. Borrowing credibility from a true idea and attaching it to a product’s expected return. A sector may genuinely grow; that does not mean a fund tracking it will deliver a high return after costs and after the growth is already priced in.
• Framing. Positive but empty language that sorts a product into a flattering mental category. “Smart,” “institutional,” “defined-outcome,” and “all-weather” describe a feeling, not a payoff.
• Salience. Spotlighting one attractive number, usually a high yield or distribution rate, so it crowds out the metric that actually decides the result: total return after fees, taxes, and risk.
• Shrouding. Burying the fees, bid-ask spreads, caps, surrender charges, and issuer credit risk deep in the fine print where they are hard to find and harder to compare.
• Complexity. Designing a product that is difficult to evaluate or compare, so the buyer falls back on trust and intuition instead of analysis. Complexity is itself a fee, paid in the understanding you give up.

Mapping the tactics to the products

The same five tactics show up across the most-marketed corner of finance. The table pairs each product with the feature its marketing emphasizes, the tactic doing the work, and the tradeoff to examine before buying. The base rates are unforgiving: most active funds underperform their benchmark after fees over time.⁴

The products that already have a closer look

Several of these have a full treatment elsewhere on Summitward, each a case study in one of the tactics:

• Covered-call ETFs and cash-secured puts show how a distribution yield (salience) hides capped upside and retained downside.
• Dividends show transference at work: a payout framed as income when the share price drops by the same amount.
• Permanent insurance and annuities show complexity bundling two goals to raise fees and lower transparency.
• Margin and leverage show framing that turns market declines into forced-sale risk.
• Advisor fee models show how conflating fee structure, fiduciary status, and compensation source obscures the conflict.

The white-space products worth naming directly

A few of the most-marketed products are worth a closer look because the pitch and the reality diverge sharply.

Thematic ETFs. A fund launches around an exciting narrative after the sector has already run, and excited buyers become insensitive to fees. In the largest study of the category, specialized ETFs underperformed the broad market by about 30% in risk-adjusted terms over their first five years, driven by the overvaluation of the underlying stocks at launch.⁵

Private equity and private credit. The pitch is institutional access, high yield, and low volatility. The low volatility is partly an artifact of appraisal-based marks rather than market prices, a smoothing that some observers call volatility laundering. Evidence on returns is mixed: some older buyout vintages beat public markets, while research by Ludovic Phalippou finds post-2006 buyout funds delivered net returns broadly similar to public equity indices after fees.⁶ The IMF has flagged private credit specifically for opacity, leverage, weak transparency, and liquidity mismatch.⁷

Structured “worst-of” notes. These package a custom payoff that depends on the worst performer in a basket, with caps, barriers, and the issuer’s credit standing behind it. In May 2026, FINRA announced a review of higher-risk structured products, focused on non-principal-protected worst-of notes, after finding that firms had concentrated customers in products whose complexity and lack of principal protection raised the risk.⁸

Leveraged and inverse ETFs. The 2x or 3x label describes a daily objective. Because the exposure resets each day, the SEC and FINRA warn that returns over periods longer than a day can differ significantly from the stated multiple, especially in volatile markets.⁹

“Free” trading apps. Zero commissions are a loss leader. The revenue moves to payment for order flow, margin interest, securities lending, and options activity, and the interface is often tuned to encourage more trading. SEC staff have noted that payment-for-order-flow arrangements create incentives around customer order flow and that lower commissions can raise trading frequency.¹⁰ Retail options trading sits inside the same economics: commissions look free while the spread and order-flow value are where the cost lives, and studies document large aggregate losses for retail option traders.

Six lenses that cut through any pitch

“Watch out for high fees” is too narrow. A product can be cheap on the expense ratio and still be a poor deal. Run any pitch through six lenses.

1. Cost drag. Every layer: expense ratio, advisory fee, fund-of-funds fees, loads, surrender charges, embedded derivative costs, bid-ask spreads, margin interest, and tax drag.
2. Payoff asymmetry. What you give up for the headline feature. Covered calls sell upside; structured notes may sell away dividends, liquidity, or protection under certain conditions; leveraged products magnify drawdowns.
3. Liquidity. Private funds, annuities, interval funds, and structured notes can be slow or costly to exit, often exactly when you want out.
4. Behavior. A legitimate product can still hurt you if it invites performance chasing, leverage, or overtrading. Morningstar measures a persistent gap between fund returns and the returns investors actually earn because of timing behavior.¹¹
5. Incentive. Whoever recommends the product may be paid by commissions, revenue sharing, spreads, order flow, or insurance compensation. Ask how they get paid if you buy.
6. Benchmark. Many pitches compare the product to cash, to inflation, or to nothing. The comparison that matters is a low-cost diversified portfolio after fees, taxes, and risk.

The loss-leader, and the subsidy you can accept

Free or near-free services exist because they feed a funnel. A platform offers zero-commission trading expecting to earn its money back when enough customers buy the heavily marketed, higher-margin products it also sells. That structure has a quiet implication for disciplined investors. If you use the free infrastructure and decline the marketed funnel, holding low-cost index funds on a zero-commission platform, you get the benefit of modern, cheap access while other customers fund the firm’s profits. The discipline is the edge.

How much a product has to beat the index just to tie

Before deciding whether a pitch is persuasive, quantify what the product has to overcome. The calculator below totals a product’s all-in annual cost and shows the required annual outperformance, the hurdle, it must clear just to match a low-cost index after costs. It also shows the terminal-wealth gap and how many years of contributions the cost gap represents. Set the costs to whatever a specific product actually charges.

Who complex products can make sense for

Complexity earns its place sometimes. A product can be the right tool for an investor with a written plan, a specific problem, liquidity elsewhere, and the ability to evaluate the payoff in plain terms. Examples include an income annuity to transfer longevity risk, options to hedge a concentrated stock position, private investments for a genuinely illiquidity-tolerant investor with access to high-quality managers, or direct indexing for a taxable investor with enough assets and volatility to generate meaningful tax-loss harvesting.

They usually do not make sense for a near-term homebuyer, an emergency-fund builder, a retiree who cannot tolerate a lockup, someone drawn mainly by a high yield, anyone using margin to chase returns, or anyone buying because a product sounds exclusive or institutional. For a typical accumulator with decades ahead, a diversified low-cost portfolio with tax discipline is already a hard benchmark to beat.

The red-flag checklist

Before buying any marketed product, answer these out loud. If you cannot answer one of them, that is the answer.

• Can I explain the payoff without marketing language?
• What is the all-in annual cost, every layer included?
• What is the worst-case loss?
• What happens if I need my money back early?
• What benchmark should this beat, and by how much after costs?
• Who gets paid if I buy, and how?
• What tax treatment applies?
• What simpler product would I compare it against?
• Is the benefit a real financial improvement or a psychological preference?

Frequently asked questions

Are all complex or actively managed products bad?

No. Some solve real problems for the right investor, such as longevity risk or hedging a concentrated position. The point is that complexity carries the burden of proof. A product should earn its place by solving a specific problem a simple low-cost portfolio does not, after fees, taxes, and liquidity are accounted for.

If a product is marketed heavily, does that make it a scam?

Not a scam, but a signal. Heavy marketing usually means high margins for the seller, which the buyer funds through costs. It raises the bar the product must clear; it does not automatically condemn the product.

Why are high distribution yields a red flag?

A high distribution rate is salient and easy to feel, but it is not the same as total return. Some of a distribution can be a return of your own capital, and strategies that fund a high yield by selling upside often deliver lower total returns than simply holding the underlying assets.

Is zero-commission trading actually free?

The trade is free; the business model is not. Revenue moves to payment for order flow, margin interest, securities lending, and options activity. You can still come out ahead by using the free access and declining the higher-margin products the platform markets.

How do I evaluate a product I do not understand?

Run it through the six lenses and the checklist above, and use the hurdle calculator to see how much it must outperform a low-cost index just to break even. If you cannot explain the payoff in plain English or name the worst-case loss, that is reason enough to pass.

Key takeaways

• The marketing budget is a cost you pay. The most heavily advertised products tend to carry the biggest economics for the seller, which raises the burden of proof.
• Name the tactic. Transference, framing, salience, shrouding, and complexity sell the feature you can feel and hide the tradeoff you live with.
• Use six lenses, not one. Cost drag, payoff asymmetry, liquidity, behavior, incentive, and benchmark catch what “watch the fees” misses.
• Quantify the hurdle. A product must out-earn a low-cost index by its full cost gap every year just to tie, and most do not.
• Complexity must earn its place. A few products fit a few investors; the default is simple, transparent, liquid, and cheap.

Related guides

• Covered Calls Are Not Free Income decomposes the yield pitch into capped upside and retained downside.
• Dividends Are Not Free Money shows why a payout is not the same as a return.
• Financial Advisor Fee Models separates fee structure, fiduciary status, and compensation source.
• Don’t Mix Insurance With Investing covers permanent insurance and annuities as complexity bundles.
• The Passive Investing Myth shows how the “passive” label hides upstream active choices.
• Personal Leverage and Margin covers how leverage turns declines into forced-sale risk.
• Systematic Investing is the disciplined alternative to the marketed funnel.
• Agentic Trading shows automation marketed as innovation while it automates the wrong behavior.

Sources

1. Felix, Ben (Portfolio Manager, PWL Capital). “The Biggest Problem in Investing Right Now” (YouTube). The conceptual inspiration for this guide, including the five-tactic framework and the loss-leader framing. The factual claims in this guide are sourced to the primary references below.
2. Gabaix, Xavier and David Laibson. “Shrouded Attributes, Consumer Myopia, and Information Suppression in Competitive Markets,” Quarterly Journal of Economics (2006).
3. U.S. Securities and Exchange Commission. Staff Bulletin: Standards of Conduct for Broker-Dealers and Investment Advisers, Conflicts of Interest. Disclosure of a conflict does not by itself satisfy a best-interest obligation.
4. S&P Dow Jones Indices. SPIVA U.S. Scorecard, Year-End 2024. 65% of active large-cap funds underperformed the S&P 500 in 2024; 89.5% underperformed over 15 years.
5. Ben-David, Itzhak, Francesco Franzoni, Byungwook Kim, and Rabih Moussawi. “Competition for Attention in the ETF Space,” Review of Financial Studies (2023). Specialized ETFs underperformed by about 30% risk-adjusted over their first five years.
6. Phalippou, Ludovic. “How Do Private Equity Investments Perform Compared to Public Equity?” Post-2006 buyout funds delivered net returns broadly similar to public equity indices. The appraisal-smoothing critique (“volatility laundering”) is associated with Cliff Asness / AQR commentary.
7. International Monetary Fund. Global Financial Stability Report. Flags private credit risks: borrower quality, leverage, valuation, liquidity mismatch, and interconnectedness.
8. FINRA. “FINRA Announces Review of Higher-Risk Structured Products” (May 2026). Review of non-principal-protected “worst-of” structured notes.
9. U.S. Securities and Exchange Commission, Investor.gov. Updated Investor Bulletin: Leveraged and Inverse ETFs. Returns over more than one day can differ significantly from the stated multiple. See also Understanding Margin Accounts and Variable Annuities.
10. U.S. Securities and Exchange Commission. Staff Report on Equity and Options Market Structure Conditions in Early 2021. Payment-for-order-flow incentives and the rise of retail options trading.
11. Morningstar. Mind the Gap 2025. The gap between fund returns and investor returns driven by timing behavior.